α-Synuclein Pathology in PRKN-Linked Parkinson's Disease: New Insights from a Blood-Based Seed Amplification Assay
Ann Neurol (2024) 95 (6), 1173-1177 DOI: 10.1002/ana.26917
Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer’s disease
Cell Rep Med (2024) 5 (8), 101669 DOI: 10.1016/j.xcrm.2024.101669
Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia
Acta Neuropathol (2024) 147 (1), 14 DOI: 10.1007/s00401-023-02657-y
A functional aged human iPSC-cortical neuron model recapitulates Alzheimer's disease, senescence, and the response to therapeutics
Alzheimer’s Dement. 2024; 20: 5940–5960. https://doi.org/10.1002/alz.14044
Deletion of miR-33, a regulator of the ABCA1–APOE pathway, ameliorates neuropathological phenotypes in APP/PS1 mice
Alzheimer’s Dement. 2024; 20: 7805–7818. https://doi.org/10.1002/alz.14243
Nanoplastics exacerbate Parkinson's disease symptoms in C. elegans and human cells
J Hazard Mater (2024) 465, 133289 DOI: 10.1016/j.jhazmat.2023.133289
Ultrasensitive and Multiple Biomarker Discrimination for Alzheimer's Disease via Plasmonic & Microfluidic Sensing Technologies
Advanced Science 2024, 11, 2308783. https://doi.org/10.1002/advs.202308783
Autoclave treatment fails to completely inactivate DLB alpha-synuclein seeding activity
Biochemistry and Biophysics Reports (2023) 34, 101446 DOI: 10.1016/j.bbrep.2023.101446
Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
J. Vis. Exp. (196), e65453, doi:10.3791/65453 (2023).
Probing the Interactions of LRP1 Ectodomain-Derived Peptides with Fibrillar Tau Protein and Its Impact on Cellular Internalization
Applied Sciences (2023) 13 (2), 853 DOI: 10.3390/app13020853